Perfromance Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Perfromance Wealth Partners's LLY Position: Q1 2026 in Review
Perfromance Wealth Partners increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $119K and bringing the position to 4,419 shares worth $4.06M. The position accounts for 0.12% of the portfolio, ranked #37.
Perfromance Wealth Partners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $62.2M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Perfromance Wealth Partners held 4,419 shares of Eli Lilly worth $4.06M as of Q1 2026.
- Perfromance Wealth Partners bought 117 Eli Lilly shares in Q1 2026, an estimated $119K.
- Eli Lilly made up 0.12% of Perfromance Wealth Partners's portfolio in Q1 2026, its #37 holding.
- Perfromance Wealth Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Perfromance Wealth Partners's Eli Lilly position peaked at $62.2M in Q3 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.